Vista Partners Updates Coverage on CytoSorbents Corporation (ticker: CTSO); $0.50 Price Target
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwired) -- 10/22/14 -- announced today that it has updated coverage on (OTCQB: CTSO) ("The Company," or "CTSO"); and maintains its twelve month price target of $0.50. Ross Silver, Principal Analyst at Vista Partners, stated, "According to the Company, CytoSorbents' flagship product is CytoSorb® which targets the treatment of life-threatening illnesses in the intensive care unit, such as sepsis, Ebola, trauma, burn injury, and many others where excessive inflammation can be deadly. CytoSorb® is the only specifically approved extracorporeal cytokine filter approved for sale in all 28 countries of the European Union and in countries that accept CE Mark approval. CytoSorb® has the potential to revolutionize critical care medicine; save lives, and reduce cost. CytoSorb® and the other products in the Company's pipeline may have significant upside, considering the massive markets they seek to address. The Company has received validation of their technology from many large organizations including: , , , , , scientific advisors & analysts. The Company enjoys a unique, high margin product and pipeline with little to no current competition."
To download a FREE copy of the research report, please visit and click the "download research" icon to gain access to the report.
About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista focuses on investing globally across all market sectors. Vista also provides investment considerations on publicly traded companies through a platform of stock research reports, newsletters, company specific webpages and daily commentary. The platform of products is meant to serve as potential tools for investors to learn about investment considerations. It is Vista's mission to provide investors with tools that may enable them to make profitable investment decisions with the goal to deliver investment considerations that outperform small, mid and large cap equity indexes.
Please follow us on & at Vista-Partners to receive updates, thoughts and ideas about and our coverage universe of companies and more.
Disclaimer & Disclosure:
For a full list of disclaimers and disclosures, please visit our website or click .
Contact:
Vista Partners
877.215.4813
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.10.2014 - 13:00 Uhr
Sprache: Deutsch
News-ID 346072
Anzahl Zeichen: 0
contact information:
Town:
SAN FRANCISCO, CA
Kategorie:
Investment Services & Trading
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Vista Partners Updates Coverage on CytoSorbents Corporation (ticker: CTSO); $0.50 Price Target"
steht unter der journalistisch-redaktionellen Verantwortung von
Vista Partners LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
